Exact Mass: 403.226

Exact Mass Matches: 403.226

Found 27 metabolites which its exact mass value is equals to given mass value 403.226, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Pleurostyline

Pleurostyline

C25H29N3O2 (403.226)


   

metergoline

benzyl N-({6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl}methyl)carbamate

C25H29N3O2 (403.226)


   

Neoperiphylline

Neoperiphylline

C25H29N3O2 (403.226)


   

Maybridge3_006700

Maybridge3_006700

C25H29N3O2 (403.226)


   

Maybridge4_004497

Maybridge4_004497

C25H29N3O2 (403.226)


   

4-phenyl-9-(3-phenyl-acryloyl)-1,5,9-triaza-cyclotridec-10-en-2-one|Neoperiphyllin|Neoperiphylline

4-phenyl-9-(3-phenyl-acryloyl)-1,5,9-triaza-cyclotridec-10-en-2-one|Neoperiphyllin|Neoperiphylline

C25H29N3O2 (403.226)


   

Metergoline phenylmethyl ester

Metergoline phenylmethyl ester

C25H29N3O2 (403.226)


   

Metergoline

Metergoline phenylmethyl ester

C25H29N3O2 (403.226)


An ergoline alkaloid that is the N-benzyloxycarbonyl derivative of lysergamine. A 5-HT2 antagonist. Also 5-HT1 antagonist and 5-HT1D ligand. Has moderate affinity for 5-HT6 and high affinity for 5-HT7. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CB - Prolactine inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist relative retention time with respect to 9-anthracene Carboxylic Acid is 0.923 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.918 Metergoline is a serotonin (5-HT) receptor and dopamine receptors antagonist, with pKis of 8.64, 8.75 and 8.75 for 5-HT2A, 5-HT2B and 5-HT2C, respectively. Metergoline is a high-affinity ligand for the h5-HT7 receptor, with a Ki of 16 nM. Metergoline is also a reversible neural Na+ channels inhibitor. Metergoline is commonly used for the research of seasonal affective disorder, prolactin hormone regulation[1][2][3].

   

Azepino[4,5-b]indole-5-carboxylic acid, 1,2,3,6-tetrahydro-1,1-dimethyl-8-[methyl(phenylmethyl)amino]-, ethyl ester

Azepino[4,5-b]indole-5-carboxylic acid, 1,2,3,6-tetrahydro-1,1-dimethyl-8-[methyl(phenylmethyl)amino]-, ethyl ester

C25H29N3O2 (403.226)


   

1H-Indole-1-carboxylic acid, 3-(1-cyano-1-methylethyl)-6-[methyl(phenylmethyl)amino]-, 1,1-dimethylethyl ester

1H-Indole-1-carboxylic acid, 3-(1-cyano-1-methylethyl)-6-[methyl(phenylmethyl)amino]-, 1,1-dimethylethyl ester

C25H29N3O2 (403.226)


   

2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate

2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate

C25H29N3O2 (403.226)


   

Poly(styrene-co-4-bromostyrene-co-divinylbenzene)

Poly(styrene-co-4-bromostyrene-co-divinylbenzene)

C25H29N3O2 (403.226)


   

N-((2-Methoxypyridin-4-yl)methyl)-1-(1-(naphthalen-1-yl)ethyl)piperidine-4-carboxamide

N-((2-Methoxypyridin-4-yl)methyl)-1-(1-(naphthalen-1-yl)ethyl)piperidine-4-carboxamide

C25H29N3O2 (403.226)


   

(R)-N-((2-Methoxypyridin-4-yl)methyl)-1-(1-(naphthalen-1-yl)ethyl)piperidine-4-carboxamide

(R)-N-((2-Methoxypyridin-4-yl)methyl)-1-(1-(naphthalen-1-yl)ethyl)piperidine-4-carboxamide

C25H29N3O2 (403.226)


   

(3aS,4R,9bR)-4-(hydroxymethyl)-5-methyl-8-(2-phenylethynyl)-N-propan-2-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide

(3aS,4R,9bR)-4-(hydroxymethyl)-5-methyl-8-(2-phenylethynyl)-N-propan-2-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide

C25H29N3O2 (403.226)


   

(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-(2-phenylethynyl)-N-propan-2-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide

(3aR,4S,9bS)-4-(hydroxymethyl)-5-methyl-8-(2-phenylethynyl)-N-propan-2-yl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide

C25H29N3O2 (403.226)


   

4-[4-[(1S,5R)-3-[cyclobutyl(oxo)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide

4-[4-[(1S,5R)-3-[cyclobutyl(oxo)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide

C25H29N3O2 (403.226)


   

N-[4-(2,3,9,9-tetramethyl-7-oxo-6,6a,8,10-tetrahydro-5H-benzo[b][1,4]benzodiazepin-6-yl)phenyl]acetamide

N-[4-(2,3,9,9-tetramethyl-7-oxo-6,6a,8,10-tetrahydro-5H-benzo[b][1,4]benzodiazepin-6-yl)phenyl]acetamide

C25H29N3O2 (403.226)


   

1-(8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,12-dien-1-yl)-3-phenylprop-2-en-1-one

1-(8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,12-dien-1-yl)-3-phenylprop-2-en-1-one

C25H29N3O2 (403.226)


   

(2e)-1-[(6r,10e)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one

(2e)-1-[(6r,10e)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one

C25H29N3O2 (403.226)


   

(2e)-1-[(6s,12z)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,12-dien-1-yl]-3-phenylprop-2-en-1-one

(2e)-1-[(6s,12z)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,12-dien-1-yl]-3-phenylprop-2-en-1-one

C25H29N3O2 (403.226)


   

9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one

9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one

C25H29N3O2 (403.226)


   

(2z)-1-[(6r,10e)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one

(2z)-1-[(6r,10e)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one

C25H29N3O2 (403.226)


   

(7r,13r)-9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one

(7r,13r)-9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one

C25H29N3O2 (403.226)


   

(2e)-1-[(6s,10z)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one

(2e)-1-[(6s,10z)-8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl]-3-phenylprop-2-en-1-one

C25H29N3O2 (403.226)


   

(7s,13r)-9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one

(7s,13r)-9-hydroxy-7-phenyl-1,6,10-triazatricyclo[11.9.0.0¹⁴,¹⁹]docosa-9,14,16,18,20-pentaen-22-one

C25H29N3O2 (403.226)


   

1-(8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl)-3-phenylprop-2-en-1-one

1-(8-hydroxy-6-phenyl-1,5,9-triazacyclotrideca-8,10-dien-1-yl)-3-phenylprop-2-en-1-one

C25H29N3O2 (403.226)